Monopar Therapeutics Stock - Thursday chart and volatility snapshot
18.06.2026 - 18:40:32 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 18:32 CET. Details in the imprint.
Monopar Therapeutics (US6093601054) is trading on Nasdaq without any new corporate filings or major news on Thursday. With no fresh hook from the company or from leading wire services, the focus turns to the stock’s latest chart picture and trading volatility.
Background and price data on Monopar Therapeutics
Key company news, filings and historical price data on Monopar Therapeutics stock are collected in the dedicated topic section at ad-hoc-news.de.
What recent prices show
According to MarketBeat data, Monopar Therapeutics shares most recently closed at $64.39 on 06/17/2026 after regular trading hours on Nasdaq. Extended trading around that close was reported unchanged at $64.39, indicating muted activity outside the main session.
The quoted level near the mid-$60s marks a significant move compared with the company’s earlier history as a low-priced clinical-stage biotech. MarketBeat’s overview also notes that the latest close followed a 3.27% gain on the day, highlighting elevated daily volatility in the stock.
Thursday focus on chart and volatility
With no new press release on the company’s investor relations page and no mention in the Thursday market roundups of major wire services such as Reuters, the key lens for the day is technical rather than fundamental. This is typical for smaller biotech names between trial or funding milestones.
Recent trading has featured sizable percentage swings on relatively low absolute volume, a combination that can make short-term moves sharper than in larger, more liquid pharma stocks. For retail investors, that usually means wider intraday ranges and a greater role for trading discipline when entering or exiting positions.
The business behind the ticker
Monopar Therapeutics develops therapeutics for cancer patients, focusing on areas of high unmet medical need. As a clinical-stage company, its value drivers are primarily drug candidates in development, regulatory interactions and funding events, rather than steady product sales and cash flows.
Where the stock trades today
The shares of Monopar Therapeutics (US6093601054) trade on Nasdaq in US dollars; the most recently referenced closing price was $64.39 on 06/17/2026 at 04:00 PM Eastern Time.
Key facts on Monopar Therapeutics stock
- Company: Monopar Therapeutics Inc.
- ISIN: US6093601054
- Ticker: MNPR
- Venue: Nasdaq
- Price (as of 06/17/2026, 16:00 Eastern Time): 64.39 USD
- Sector / Industry: Health Care / Biotechnology
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
